SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response

In the past year and a half, SARS-CoV-2 has caused 240 million confirmed cases and 5 million deaths worldwide. Autophagy is a conserved process that either promotes or inhibits viral infections. Although coronaviruses are known to utilize the transport of autophagy-dependent vesicles for the viral life cycle, the underlying autophagy-inducing mechanisms remain largely unexplored. Using several autophagy-deficient cell lines and autophagy inhibitors, we demonstrated that SARS-CoV-2 ORF3a was able to induce incomplete autophagy in a FIP200/Beclin-1-dependent manner. Moreover, ORF3a was involved in the induction of the UPR (unfolded protein response), while the IRE1 and ATF6 pathways, but not the PERK pathway, were responsible for mediating the ORF3a-induced autophagy. These results identify the role of the UPR pathway in the ORF3a-induced classical autophagy process, which may provide us with a better understanding of SARS-CoV-2 and suggest new therapeutic modalities in the treatment of COVID-19.

Automated summary

The ORF3a protein of SARS-CoV-2 induces incomplete autophagy in a FIP200/Beclin-1-dependent manner and is involved in the induction of the UPR. The IRE1 and ATF6 pathways mediate the ORF3a-induced autophagy process. These findings enhance our understanding of SARS-CoV-2 and suggest new therapeutic approaches for treating COVID-19.